Molecular Signatures of Neuroinflammation Induced by αSynuclein Aggregates in Microglial Cells

Abstract

Alpha-synuclein (αSyn_Agg) are pathological hallmarks of Parkinson's disease (PD) and other synucleinopathies that induce microglial activation and immune-mediated neurotoxicity, but the molecular mechanisms of αSyn_Agg-induced immune activation are poorly defined. We performed quantitative proteomics by mass spectrometry coupled with PCR, immunohistochemical and functional validations studies to define the molecular characteristics of alpha synuclein mediated microglial activation. In mouse microglia, αSyn_Agg induced robust pro-inflammatory activation (increased expression of 864 genes including <i>Irg1, Ifit1</i>, and <i>Pyhin</i>) and increased nuclear proteins involved in RNA synthesis, splicing, and anti-viral defense mechanisms. Conversely, αSyn_Agg decreased expression several proteins (including Cdc123, Sod1, and Grn), which were predominantly cytosolic and involved in metabolic, proteasomal and lysosomal mechanisms. Pathway analyses and confirmatory <i>in vitro</i> studies suggested that αSyn_Agg partly mediates its effects via Stat3 activation. As predicted by our proteomic findings, we verified that αSyn_Agg induces mitochondrial dysfunction in microglia. Twenty-six proteins differentially expressed by αSyn_Agg were also identified as PD risk genes in genome-wide association studies (upregulated: Brd2, Clk1, Siglec1; down-regulated: Memo1, Arhgap18, Fyn, and Pgrn/<i>Grn</i>). We validated progranulin (PGRN) as a lysosomal PD-associated protein that is downregulated by αSyn_Agg in microglia <i>in-vivo</i> and is expressed by microglia in post-mortem PD brain, congruent with our <i>in vitro</i> findings. <b>Conclusion:</b> Together, proteomics approach both reveals novel molecular insights into αSyn-mediated neuroinflammation in PD and other synucleinopathies.